Rafoxanide Suspension: Effective Anthelmintic for Liver Fluke in Cattle and Sheep
Introduction
Rafoxanide Suspension is a highly effective anthelmintic medication specifically designed for the treatment of liver fluke infections in cattle and sheep. Manufactured by Kaifeng Darui Pharmaceutical Co., Ltd., a leading high-tech enterprise in China’s pharmaceutical industry, this product represents cutting-edge veterinary medicine. With a commitment to quality, innovation, and sustainability, Kaifeng Darui ensures that Rafoxanide Suspension meets the highest standards of efficacy and safety.
Product Details
Composition
- Active Ingredient: Rafoxanide (C19H11Cl2I2NO3)
- Content: 90.0% to 110.0% of the labeled amount
- Appearance: Grayish-white suspension liquid
Indications
Used to treat liver fluke disease in cattle and sheep.
Usage and Dosage
| Parameter | Details |
|---|---|
| Administration | Oral |
| Dosage | 7 to 12 mg per kg of body weight for cattle and sheep |
Contraindications
- Do not use in dairy cattle and sheep producing milk for human consumption during the lactation period.
- Avoid overdose.
Withdrawal Period
60 days for cattle and sheep.
Storage
Protect from light and store in a sealed container.
About Kaifeng Darui Pharmaceutical Co., Ltd.
Kaifeng Darui Pharmaceutical Co., Ltd. is a high-tech enterprise established in 2020, located in the Kaifeng Fine Chemical Park, Henan, China. With a registered capital of ¥27 million, the company specializes in the research, development, production, and sales of pharmaceutical raw materials, food additives, and veterinary APIs. Kaifeng Darui is committed to innovation and sustainability, offering a range of services tailored to meet the needs of its clients.
Products and Services
- R&D, Production, and Sales: Pharmaceutical raw materials, food additives, and veterinary APIs.
- Custom R&D: Fine chemical intermediates, safe food additives, and OEM-ready veterinary APIs.
- Focus Areas: Alkane bromination and bio-pharmaceuticals, including antiviral and pet antiparasitic APIs, as well as veterinary drug formulations.
Facilities and Infrastructure
| Facility | Description |
|---|---|
| API Facility | 700㎡ with synthesis and purification capabilities |
| Cleanroom | Grade D with isolated air purification |
| Key Equipment | Shimadzu HPLC, Fourier-transform IR spectrometers, stability test chambers, distillation units |
| Eco-Friendly Features | 150t/d wastewater treatment, RCO exhaust systems |
| QC Labs | Equipped with HPLC, GC, and UV-Vis spectrophotometry |
R&D and Innovation
- Team: Over 20 R&D specialists, including 2 senior engineers and 2 associate professors; 70% hold bachelor’s degrees or higher.
- Patents: 12 utility patents (e.g., bromonitro alcohol purification, albendazole catalytic systems) and 4 pending patents.
- Collaborations: Henan Academy of Sciences, Pingdingshan University.
Financial Performance (2024)
- Output: Exceeded ¥60 million.
- Taxes Paid: ¥2 million.
Future Goals (by 2025)
- Annual Output: ¥100 million.
- R&D Investment: ¥20 million.
- New Products: Launch 2-3 core products.
- Enterprise Status: Achieve SRDI status.
Certifications and Honors
- National High-Tech Enterprise (2023)
- Henan Provincial Innovative SME (2022)
- Kaifeng Alkane Bromination Engineering Center (2023)
- Charity Recognition Award (2023)
- Member of the Kaifeng Pharmaceutical Association Council (2024)
Services Offered
Processing on Behalf of Customers (CDMO Services)
We provide contract development and manufacturing organization (CDMO) services, allowing clients to leverage our expertise and state-of-the-art facilities for their pharmaceutical needs.
Customized Production
Our advanced R&D capabilities enable us to offer customized production solutions, ensuring that our products meet specific client requirements.
Supplying Neutral Large Packaging
We supply neutral large packaging options, providing flexibility and convenience for our clients’ packaging needs.
Why Choose Kaifeng Darui Pharmaceutical Co., Ltd.?
- Quality Assurance: Stringent quality control processes ensure the highest standards of product efficacy and safety.
- Innovation: A dedicated R&D team and a portfolio of patents demonstrate our commitment to advancing veterinary pharmaceuticals.
- Sustainability: Eco-friendly facilities and practices reflect our responsibility to the environment.
- Global Reach: Our products are trusted by veterinary professionals worldwide, with a focus on meeting international standards.
Contact Information
For inquiries, orders, or further information, please contact us at:
- Address: Kaifeng Fine Chemical Park, Henan, China
- Telephone: +86-13837178289
- Email: info@daruipharm.com
Visit our website at Kaifeng Darui Pharmaceutical for more details.
